OasisLMS

ACMG Education Webinar Series: Translating Genes into Health®

Date of Release: July 2, 2025

Expiration Date: July 2, 2027

Credits offered: AMA PRA Category 1 Credits™

Estimate time of completion: 1.0 hour

Genomics-Informed Government Policy: Starting the Conversation with Policymakers

Sponsored by The ACMG Advocacy and Government Affairs Committee

Description

As genomics becomes increasingly central to patient care and public health, policymakers face urgent questions around access, oversight, and public trust. This session brings together experts from science, policy, and public service to explore how federal, state, and local policies can evolve alongside genomic innovation—while remaining equitable, ethical, and grounded in scientific evidence.

Genetics professionals are uniquely positioned to help guide these conversations and serve as trusted advisers. This session will offer practical support on how to begin those discussions, with panelists sharing insights from Capitol Hill, the Administration, and the medical community.

Target Audience

Designed for genetics professionals, policy leaders, and advocates, the session will offer real-world strategies for engaging with government stakeholders and shaping genomics-informed policy.

Learning Objectives

At the conclusion of this session, participants should be able to:

• Describe effective strategies for engaging with policymakers at various levels of government.
• Explain how genomics professionals can contribute to equitable, science-based policy development.
• Identify common challenges and best practices for building relationships between scientific and policy communities.

Moderator: 

Heather E. Williams, PhD, MBA, MS, FACMG Co-Founder & Principal Consultant Medical Director GeneBetween

Presenters: 

	Karen A. Robinson, MPA Senior Advisor, Equity Research and Innovation Center Yale School of Medicine
	Chris Kelly BGR Group
	Senator Daniel Zilkinov Montana State Legislature
	Julie Neidich, MD, FACMG Professor of Pathology and Immunology, Division of Genomics and Molecular Pathology, and of Pediatrics, Division of Genetics and Genomics Washington University in St. Louis (WashU Medicine)

Planners

Henry J. Mroczkowski, MD, PhD, FACMG (Chair)

University of TN Health Science Ctr

Jane Radford, MHA, CHCP

Director of Education - ACMG

Heather E. Williams, PhD, MBA, MS, PgD, ErCLG

Co-Founder & Principal Consultant Medical Director

GeneBetween

Michelle McClure, PhD

Public Policy Director

American College of Medical Genetics and Genomics

Julie Neidich, MD, FACMG
Professor Pediatrics, Division of Genetics and Genomics

Medical Director, Clinical Genomics/Cytogenetics and Molecular Pathology Core Lab

Medical Director (Former), Cytogenetics & Molecular Pathology Lab

Medical Director (Former), Molecular Diagnostic Lab

Department of Pathology & Immunology

Washington University in St. Louis

CME AMA PRA Category 1 Credits^TM

Accreditation

The American College of Medical Genetics and Genomics is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Designation

The American College of Medical Genetics and Genomics designates this enduring activity for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The American Medical Association (AMA) defines physicians as those individuals who have obtained an MD, DO, or equivalent medical degree from another country. Non-physicians may request a certificate of attendance for their participation.

Claiming your Educational Credits

This activity consists of: View content, take a post-test, the test may be taken as often as necessary to achieve a passing score of 80% or better is required to receive credit.  If you do not achieve a passing score, the program will identify which questions you answered incorrectly so that you can review the module and try again. Complete the evaluation form.

Learner Data Consent

ACMG Education reports learner data to respective agency boards and you will be asked for consent during the evaluation process. Your compliance with deadlines and completing evaluations are part of the process in meeting learner needs and ACMG’s education mission.

Technical Support:
You can reach us by email at education@acmg.net or call 301-718-9603.
Support Center Hours: Monday – Friday, 9:00 AM – 5:00 PM Eastern Time.

Accredited Continuing Education Financial Disclosure

The American College of Medical Genetics and Genomics (ACMG) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide Accredited Continuing Education (ACE) for physicians. ACMG is an organization committed to improvement of patient care and general health by the incorporation of genetics and genomics into clinical practice.

ACMG has implemented the following procedures to ensure the independence of ACE activities from commercial influence/promotional bias, the Accreditation Council for Continuing Medical Education (ACCME) requires that providers (ACMG) must be able to demonstrate that: 1) everyone in a position to control the content of an ACE activity has disclosed all financial relationships that they have had in the past 24 months with ineligible* companies; 2) ACMG has implemented a mechanism to mitigate relevant financial relationships; and 3) all relevant financial relationships with ineligible companies are disclosed to the learners before the beginning of the educational activity. The learners must also be informed if no relevant financial relationships exist.
*Ineligible companies are defined as those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

ACMG Education Policies

Please review the policies below regarding the ACMG Education program

• Financial Disclosures and Mitigation Procedure
• ACMG Content Validation Policy
• ACMG Content Branding Policy

All of the relevant financial relationships listed for these individuals have been mitigated.

Disclaimer

ACMG educational programs are designed primarily as an educational tool for health care professionals who wish to increase their understanding of the application of genomic technologies to patient care. The ACMG does not endorse or recommend the use of this educational program to make patient diagnoses, particular by individuals not trained in medical genetics. Adherence to the information provided in these programs does not necessarily ensure a successful diagnostic outcome. The program should not be considered inclusive of all proper procedures and or exclusive of other procedures and that are reasonably directed at obtaining the same results. In determining the propriety of any specific procedure or, a healthcare professionals should apply his or her own professional judgment to the specific clinical circumstances presented by the individual patient or specimen.

Questions regarding CE credit should be directed to education@acmg.net